The Jacobs Institute has close partnerships with Kaleida Health, a private hospital system, and with the University at Buffalo. These partnerships allow for greater access to and collaboration with researchers and physicians specializing in vascular disease. They include neurosurgeons, cardiac surgeons, peripheral vascular surgeons, and cardiac electrophysiology surgeons.
Dr. L. Nelson Hopkins is founder and chief scientific officer of the Jacobs Institute. He was professor and chairman of the University at Buffalo (UB) Department of Neurosurgery and professor of radiology at the UB School of Medicine and Biomedical Sciences from 1989 to 2013. Dr. Hopkins was appointed SUNY Distinguished Professor, the highest rank of faculty in the SUNY system, in recognition of his extraordinary achievements, in January 2013. He is also founder of Kaleida Health’s Gates Vascular Institute (GVI).
He completed his undergraduate studies at Rutgers University and earned his medical degree cum laude from Albany Medical College. His post-graduate training included a surgical internship at Case Western Reserve, followed by neurology and neurosurgical training at UB.
Dr. Hopkins pioneered endovascular neurosurgery, a subspecialty dedicated to minimally invasive treatment of vascular diseases of the brain and spine and has trained a new generation of neurosurgeon leaders skilled in catheter-based technology for minimally invasive neurosurgery.
He has served as a member of the board of directors of the American Association of Neurological Surgeons (AANS) and of the Executive Committee of the Stroke Council of the American Heart Association. He has served as Scientific and Annual Meeting Chairman for both the AANS and Congress of Neurological Surgeons. He is the former chairman of the Joint Section on Cerebrovascular Surgery and president of the American Academy of Neurological Surgery.
Dr. Hopkins has been the principal investigator of several national clinical trials testing catheter-based technologies for the treatment of neurovascular diseases. He is the endovascular principal for the editorial board of Neurosurgery, and the author of more than 300 publications centered on the prevention and treatment of stroke.
Dr. Adnan H. Siddiqui, is Chief Executive Officer & Chief Medical Officer of the Jacobs Institute (JI). His goal is to improve the JI’s current offerings and translate technologies being developed in the Institute’s i2R, or idea to Reality Center, into therapeutic and commercial successes.
Dr. Siddiqui is also vice-chairman and professor of neurosurgery at the State University of New York at Buffalo (UB) Jacobs School of Medicine and Biomedical Sciences. He is the director of neuroendovascular research and stroke service at Kaleida Health’s Gates Vascular Institute (GVI), and director of the UB Canon Stroke & Vascular Research Center (CSVRC). He is also a practicing surgeon with the University at Buffalo Neurosurgery (UBNS) which is part of of UBMD Physicians’ Group, a clinical practice where he sees and treats patients.
He completed fellowship training in interventional neuroradiology, cerebrovascular surgery, and neurocritical care from Thomas Jefferson University in Philadelphia. He completed his neurosurgical residency at Upstate Medical University and received his PhD in neuroscience from the University of Rochester and medical degree from Aga Khan University in Pakistan. He is a fellow of the American Association of Neurological Surgeons (AANS), American College of Surgeons (ACS), and American Heart Association (AHA), and member of the Society of Neurological Surgeons (Senior Society) and Academy of Neurological Surgeons (the Academy).
Dr. Siddiqui has over 450 peer reviewed publications, more than 50 chapters, almost 70,000 citations and an H index of 72. He is particularly proud of representing Buffalo and the US at most major cerebrovascular conferences around the world with over 200 international presentations to date. He has designed, conducted, and lead multiple major national and international clinical trials and currently serves as national and international principal investigator (PI) for multiple major funded multi-site trials. These efforts have significantly contributed to the success of the department, which was ranked 7th in academic impact in North America by the Journal of Neurosurgery.
He also serves as director of the Canon Stroke and Vascular Research Center (CSVRC) at UB. This multi-disciplinary center, with multiple concurrent major National Institute of Health (NIH) grants, houses neurosurgeons, neuroscientists, physicists and biomedical engineers working collaboratively on cutting edge research focused on neurovascular biology and pathology including stroke and aneurysms, imaging, simulation, and hemodynamics. He is the Fellowship Director for Buffalo’s prestigious Neuroendovascular Program. In addition, he serves as the director of the Neurosurgical Stroke Service at the GVI, one of the busiest Comprehensive Stroke Services in New York State and the US.
Dr. Siddiqui has continuously served on multiple scientific and educational committees of AANS, Congress of Neurological Surgeons (CNS) and Society of NeuroInterventional Surgery (SNIS). He is the chairman of the Joint Section of Cerebrovascular Surgery of the AANS and CNS and secretary for the SNIS. It has been a major focus for him to achieve consensus between the various organizations involved in fellowship training and credentialing for Neuroendovascular Surgery. He was a founding member of the Neuroendovascular Surgery Advisory Committee (NESAC) for Society of Neurological Surgery’s Committee for Advanced Sub-Specialty Training (CAST) and currently is a member of the American Board of Neurological Surgery’s (ABNS) Central Nervous System Endovascular Surgery Advisory Committee (CESAC). This has been an extremely important role, which is profoundly affecting the training and education pathways of neuroendovascular specialists.
He serves as a neurosurgeon director on the executive committee of the SNIS Patient Safety Organization which runs the NVQI-QOD Quality Outcomes Registry. He was nominated as a co-chair for the Devices for Acute Ischemic Stroke Intervention (DAISI) a Coordinated Registry network run collaboratively by the US Food and Drug Administration (FDA), Centers for Medicare and Medicaid Services (CMS), and NIH with partnership with physician societies and industry. He is committed to this singular opportunity to unify the multi-specialty neuroendovascular surgery field to develop robust prospective quality outcomes databases to shepherd the next generation of evidence-based practice. Recently, he has assumed the role of co-chair of the Neurological Devices Working group for the Medical Device Industry Consortium (MDIC), a not-for-profit group consisting of FDA, CMS, and industry partners dedicated to resuming Early Feasibility Studies (EFS) also known as First in Human studies in the US.
Dr. Siddiqui has special interest and expertise in the performance of complementary microsurgical, radiosurgical, and endovascular techniques for the comprehensive management of cerebrovascular conditions. This spectrum of disease includes aneurysms and arteriovenous malformations, as well as dural, cavernous, and spinal fistulae. He has special interests in endovascular management of acute ischemic stroke, as well as endovascular and microsurgical management of extracranial and intracranial vascular occlusive disease. Other clinical interests include endovascular management of intractable epistaxis, facial vascular malformations, head, neck, and brain tumor embolization, and microsurgical resection of skull base tumors. He is profoundly indebted to his mentors Nick Hopkins, Robert Rosenwasser, Charles Hodge, and Shirley Joseph in shaping his career as a dual-trained cerebrovascular surgeon, clinician scientist and entrepreneur.
All these efforts as a microsurgeon, endovascular surgeon, scientist, and trialist, have allowed Dr. Siddiqui to gain unique insights into a critical and rapidly evolving specialty. At the same time, these endeavors have required significant collaborations resulting in strong and trusting relationships with fellow neurosurgeons, neurologists, neuroradiologists, scientists, engineers, regulatory officers, and industry.
Dr. Siddiqui is married and has three children. He is a proud Buffalonian who is challenged and invigorated by taking care of neurosurgical patients and their families. He is most gratified by his pedagogical responsibilities, which allow him the opportunity to teach medical students, residents, and fellows. He is grateful for the opportunity to work at UB’s Department of Neurosurgery, CSVRC, GVI, and JI facilities, with some of the world’s best technologies and greatest vascular specialists, researchers, and biomedical engineers who are collaborating to advance the care of vascular diseases.
Conflicts & Disclosures
Current Research Grants:
Co-investigator for NIH – 1R01EB030092-01, Project Title: High Speed Angiography at 1000 frames per second; Mentor for Brain Aneurysm Foundation Carol W. Harvey Chair of Research, Sharon Epperson Chair of Research, Project Title: A Whole Blood RNA Diagnostic for Unruptured Brain Aneurysm: Risk Assessment Prototype Development and Testing
Financial Interest/Investor/Stock Options/Ownership:
Adona Medical, Inc., Amnis Therapeutics, Bend IT Technologies, Ltd., BlinkTBI, Inc, Buffalo Technology Partners, Inc., Cardinal Consultants, LLC, Cerebrotech Medical Systems, Inc, Cerevatech Medical, Inc., Cognition Medical, CVAID Ltd., Endostream Medical, Ltd, Imperative Care, Inc., Instylla, Inc., International Medical Distribution Partners, Launch NY, Inc., NeuroRadial Technologies, Inc., Neurotechnology Investors, Neurovascular Diagnostics, Inc., PerFlow Medical, Ltd., Q’Apel Medical, Inc., QAS.ai, Inc., Radical Catheter Technologies, Inc., Rebound Therapeutics Corp. (Purchased 2019 by Integra Lifesciences, Corp), Rist Neurovascular, Inc. (Purchased 2020 by Medtronic), Sense Diagnostics, Inc., Serenity Medical, Inc., Silk Road Medical, Spinnaker Medical, Inc., StimMed, LLC, Synchron, Inc., Three Rivers Medical, Inc., Truvic Medical, Inc., Vastrax, LLC, VICIS, Inc., Viseon, Inc.
Amnis Therapeutics, Apellis Pharmaceuticals, Inc., Boston Scientific, Canon Medical Systems USA, Inc., Cardinal Health 200, LLC, Cerebrotech Medical Systems, Inc., Cerenovus, Cerevatech Medical, Inc., Cordis, Corindus, Inc., Endostream Medical, Ltd, Imperative Care, Integra, IRRAS AB, Medtronic, MicroVention, Minnetronix Neuro, Inc., Penumbra, Q’Apel Medical, Inc., Rapid Medical, Rebound Therapeutics Corp., Serenity Medical, Inc., Silk Road Medical, StimMed, LLC, Stryker Neurovascular, Three Rivers Medical, Inc., VasSol, Viz.ai, Inc., W.L. Gore & Associates
National PI/Steering Committees:
Cerenovus EXCELLENT and ARISE II Trial; Medtronic SWIFT PRIME, VANTAGE, EMBOLISE and SWIFT DIRECT Trials; MicroVention FRED Trial & CONFIDENCE Study; MUSC POSITIVE Trial; Penumbra 3D Separator Trial, COMPASS Trial, INVEST Trial, MIVI neuroscience EVAQ Trial; Rapid Medical SUCCESS Trial.
Dr. Iyer is an interventional cardiologist specializing in structural heart interventions. His clinical practice includes general cardiology, interventional cardiology and complex valvular heart diseases. He directs a complex valve clinic, as well as structural heart interventions at the Gates Vascular Institute (GVI) and Buffalo General Medical Center (BGMC). In that capacity, he performs transcatheter aortic valve replacements (TAVR), mitral clip procedures, left atrial appendage occlusion, atrial and ventricular septal defect closure, and percutaneous paravalvular leak closures. He also cares for patients by performing routine diagnostic coronary angiograms and percutaneous coronary interventions (PCI)/angioplasty.
His research interests are in new devices for aortic and mitral valve replacement, novel therapeutics in the form of stem cells and newer therapies for acute coronary syndromes. He also collaborates with the Toshiba Stroke and Vascular Research Center to develop advanced imaging modalities in the cardiac catheterization laboratory. Dr. Iyer is also investigating the use of robotic PCI to improve precision in stent placement and reduce radiation dosage in the catheterization laboratory, and he serves as the local principal investigator for a number of multicenter clinical trials in these areas.
Dr. Iyer received his medical degree in internal medicine from Grant Medical College, Maharashtra University of Health Sciences and his PhD in pharmacology from Drexel University in Philadelphia. Dr. Iyer was a postdoctoral fellow in the division of cardiology at University at Buffalo (UB). He also completed a fellowship in cardiovascular disease from UB and then a fellowship in interventional cardiology at University of Minnesota. Among his accolades are the American Heart Association Postdoctoral Fellowship, Young Investigator Award for New York State American College of Cardiology, and Northwestern University Young Investigators Forum Finalist. He is a current Fellow of the American College of Cardiology and the Society for Coronary Angiography and Interventions.
Dr. Elad Levy is professor and chairman of neurosurgery, and professor of radiology at University at Buffalo (UB). Dr. Levy joined the department in 2004. He is the medical director of neuroendovascular services at the Gates Vascular Institute (GVI) and is board-certified by the American Board of Neurological Surgeons. Dr. Levy is the director of stroke research, co-director of Kaleida Health Stroke Center and Cerebrovascular Surgery, director of endovascular stroke treatment and research, and director of endovascular stroke treatment and research.
He graduated from Dartmouth College and received his Doctor of Medicine degree with distinction from The George Washington University. He completed a surgical internship and his neurosurgical residency at the University of Pittsburgh and his fellowship at UB. He also received his MBA from Northeastern University in 2013.
Dr. Levy has participated in several clinical research studies on synthetic bone, carotid artery revascularization, and stents. Recently, he has become involved with a study investigating concussion injury as it relates to blood-flow physiology of the brain. Companies such as Boston Scientific, Cordis, Micrus, ev3, and Abbott Vascular have solicited Dr. Levy for research projects, consultant roles, symposium speaking engagements, and physician training requests. He has been published in numerous peer-reviewed journals and has presented at both national and international meetings. Additionally, he has trained several physicians throughout the world in using complex endovascular neurosurgical techniques. Dr. Levy is also the principal investigator for flow diverting technologies.
He is a member of the American Association of Neurological Surgeons(AANS) and Congress of Neurological Surgeons (CNS). He is an ex officio member of the Executive Council for the AANS/CNS Cerebrovascular Section. Dr. Levy was also a Fellow of both the American College of Surgeons and the American Heart Association/American Stroke Association. He was also chair of the Compliance and Ethics Committee for CNS.
Dr. Kim is board-certified in cardiovascular disease and clinical cardiac electrophysiology. He is a member of Great Lakes Cardiology, a private practice. In addition to the practice, Dr. Kim is director of Electrophysiology Innovation and Clinical Integration for the Jacobs Institute and Kaleida Health’s Gates Vascular Institute.
He was previously the director of the Electrophysiology and Pacemaker Service at Rochester General Hospital in New York.
He earned his bachelor’s degree at Cornell University in Ithaca, N.Y., and his medical degree at Case Western Reserve University in Cleveland, O.H. Dr. Kim completed Internal Medicine specialty training at the University of Rochester School of Medicine. He also received cardiology and cardiac electrophysiology fellowships at the University of Rochester, where he was the chief cardiology fellow.
Dr. Kim is a member of the American Heart Association, and a fellow of the American College of Cardiology. He has authored or co-authored articles and abstracts on his research and clinical practice for numerous medical journals and publications. In addition, he has lectured and presented at national meetings and conferences.
Dr. Jason Davies is Research Director at the Jacobs Institute. He is also an Assistant Professor of Neurosurgery and Biomedical Informatics at the State University of New York (SUNY) at Buffalo, where he joined the department in 2016. He completed residency training in the Department of Neurological Surgery at University of California, San Francisco. He completed a fellowship in endovascular neurosurgery with UB Neurosurgery and specializes in cerebrovascular and skull base neurosurgery. He has extensive experience treating aneurysms, arteriovenous malformations, cavernous malformations, and arteriovenous fistulae, stroke, carotid stenosis, cerebral bypass, and other vascular disease using both open and endovascular approaches.
Dr. Davies graduated from Stanford University with a B.S. in Chemistry and a minor in Biological Sciences. He has a significant research background in molecular and cell biology, studying neuronal exocytosis proteins. After graduation, he continued his work on exocytic proteins, shifting to a molecular and computational biophysics perspective. Jason was accepted into the MD/PhD program at Stanford, where he continued his thesis work. He wrote several papers elucidating the atomic structural details of exocytic proteins and developed new computational methods for studying dynamic protein structures at high resolution in real time. During the course of his residency, he spent a one-year post-doctoral fellowship developing computational methods in natural language processing and machine learning algorithms to find ways to mine electronic medical records data.
His active research interests focus on using bioinformatics tools to advance personalized medicine. He is working to develop bioinformatics tools to improve the quantity and quality of data available for medical research, and to lower barriers to entry for all clinicians to contribute to medical knowledge. Furthermore, he is working to create more advanced machine learning and data analytic methods to better understand the insights contained within these rich data resources to better understand nuances of disease as well as which patients stand to benefit.
He has co-founded and grown several early stage medical device and medical informatics companies. He has experience developing intellectual property, conducting early phase clinical device trials, and raising capital.
Dr. Davies is married with three energetic boys. He loves cycling and skiing with his family.
Dr. Riley is Assistant Professor of Neurosurgery at University at Buffalo (UB). He is also medical director of functional neurosurgery for Kaleida Health. He specializes in neuromodulation techniques in movement disorders, epilepsies, pain syndromes, and emerging psychiatric indications. He participatedin translational and clinical research projects focused on the clinical translation of biologics-based therapeutics, with an emphasis on development of approaches to therapeutics delivery to the central nervous system. His research centers around the use of epilepsy models to develop and optimize neuromodulation-based candidate therapies for the treatment of medically refractory epilepsy.
Dr. Jeffrey Mullin is an Assistant Professor at the State University of New York at Buffalo whose clinical focus centers around spinal deformity and biomechanics as well as treatment of disorders of the cervical, thoracic, and lumbar spine. His research interests include spinal biomechanics, quality improvement/outcomes, and neurosurgical medical education. In addition to specialized spine surgery, Dr. Mullin also practices general cranial neurosurgery.
He completed a fellowship in complex deformity spine at the University of Virginia. Prior to that he had completed his general neurosurgical residency at Cleveland Clinic. He received his medical degree from Georgetown University School of Medicine in 2010. He also received his MBA from the University of Notre Dame in 2006 and completed an enfolded fellowship in epilepsy surgery at Cleveland Clinic from 2014-2016.
Dr. Mullin has authored several peer-reviewed publications and book chapters and has presented at numerous national neurosurgical meetings. He is an active member of AANS, CNS, and CSNS.
Dr. Dryjski is professor of surgery and vice-chair for faculty development at the University at Buffalo (UB) as well as the medical director of vascular and endovascular surgery for Kaleida Health. Dr. Dryjski holds a PhD from the Karolinska Institute in Stockholm, Sweden, where he studied the uptake and inhibition of Thrombin on the vessel wall and synthetic arterial grafts. He received his MD from the Medical Academy of Warsaw in Poland.
He was the recipient of the Swedish Medical Research Council Award for Research in the United States, the Am-Pol Eagle Citizen of the Year for Health/Medicine, the International Society of Endovascular Specialists Milestone Award, and the Tytus Chalubinkski Medal for Outstanding Merit to Warsaw Medical School.
Prior to coming to the U.S., Dr. Dryjski completed his internship, residency, and fellowships in Sweden where he served as a clinical fellow in the Department of Radiology at Soderjukhuset. Dr. Dryjski then served as an intern at Nacka Hospital in Stockholm for two years. For five years, he was a resident in general surgery at the Karolinska Institute and Hospital in Stockholm.
In the U.S., Dr. Dryjski served his residency in general vascular surgery for two years in the Department of Surgery at the University of South Florida in Tampa, before serving as a resident in general surgery in the department of surgery at Thomas Jefferson University in Philadelphia. He then traveled to Durham, N.C., to serve as a research associate in the division of clinical pharmacology in the department of medicine and pharmacology at Duke University Medical Center.
Dr. Dryjski has been an active member of the Association of International Vascular Surgeons (AIVS), among many other societies, and was chosen to host the 2015 annual AIVS Symposium. Dr. Dryjski is most noted for endovascular aortic repair (EVAR).
Dr. Morris joined the Buffalo Medical Group, PC, in 2000, and is board-certified in internal medicine and cardiovascular disease. He has been a clinical assistant professor of medicine at the University at Buffalo (UB) School of Medicine and Biomedical Sciences since 1987.
Dr. Morris earned his medical degree at the University of Ottawa, in Ontario, Canada. He completed internal medicine specialty training at UB and Mercy Hospital, and also did residencies in cardiology at the University of Toronto, and Wellesley and Toronto General Hospitals.
He is a member of the American Medical Association, American College of Physicians, American College of Cardiology, American Heart Association, American Society of Internal Medicine, Western New York Cardiovascular Society, and the Erie and New York State Medical societies.
Dr. Morris is affiliated with many Western New York hospitals, including Buffalo General, the Gates Vascular Institute, Suburban, Mercy, Sisters of Charity, St. Joseph’s, Lake Shore, Lockport Memorial and Roswell Park Cancer Institute.
Dr. Noor has considerable experience delivering highly skilled care in the area of endovascular surgery. She is fellowship-trained in peripheral and endovascular surgery and is board-certified in vascular and general surgery.
She attended the prestigious Calcutta Medical College in India, and subsequently completed research as a fellow in the Department of cardio-thoracic surgery at the Medical University of South Carolina. Dr. Noor started her general surgery residency at the State University at New York (SUNY) Syracuse. In 2004, she completed an endovascular fellowship at the Arizona Heart Institute in Phoenix, Arizona.
Dr. Noor is a member of the American Medical Association, Western New York Vascular Society, and Eastern Vascular Society. She is affiliated with several Western New York hospitals, including Buffalo General, the Gates Vascular Institute, Millard Fillmore Suburban Hospital, and Sisters of Charity.
Dr. Phadke has a medical degree from the Mahatma Ghandi Memorial Medical College in Indore, India, and a Membership of the Royal College of Physicians postgraduate diploma from the Royal College of Physicians of London. Dr. Phadke practiced medicine in India and the U.K. before coming to the United States in 1993.
He served as attending cardiologist and director of the Cardiac Catheterization Laboratories at the VA Medical Center and the University Hospital in Syracuse, N.Y., where he was also a Clinical Associate Professor of Medicine until he came to Buffalo in 2002. Dr. Phadke is currently a cardiologist at Northtowns Cardiology and is director of the Cardiac Catheterization Laboratory at Kaleida Health’s Gates Vascular Institute.
Dr. Phadke is a Diplomate of the American Board of Internal Medicine in Cardiovascular Diseases and Interventional Cardiology. He is a Fellow in the American College of Cardiology and a member in the American Heart Association’s Council in Clinical Cardiology.
Dr. Pollina is an Assistant Professor of Neurosurgery at University at Buffalo. He is a board certified neurosurgeron, serves as Director of Comprehensive Spine Surgery. After receiving his bachelor’s degree in economics from Fairfield University, Dr. Pollina completed medical school and his neurosurgical residency at University at Buffalo Jacobs School of Medicine & Biomedical Sciences. Dr. Pollina’s focus is on the treatment of disorders of the cervical, thoracic, and lumbar spine. His areas of expertise are in low back and neck pain, herniated disc, spinal stenosis, scoliosis, spinal instability, spinal tumor and infection, carpal/cubital tunnel syndrome, and intracranial pathology. Dr. Pollina’s research interests include motion sparing/preserving technology of the spine, minimal access approaches and techniques to the spine, osteo-biologics of spinal fusion, and spine surgery outcome-based research. Dr. Pollina performs surgeries at Buffalo General Medical Center.
Dr. Reynolds is an Assistant professor of neurosurgery at University at Buffalo. She completed her neurosurgical training at the Duke University Medical Center and received her medical degree from SUNY Upstate Medical University. She also completed a one-year fellowship at Seattle Children’s Hospital/University of Washington in pediatric neurosurgery. Dr. Reynolds is assistant program director of the department of neurosurgery’s academic & residency program. Her areas of expertise are: pediatric neurosurgery, including congenital neurosurgical conditions; brain tumors; surgical management of epilepsy; hydrocephalus; and more. Her research interests are in the areas of immunotherapy for pediatric brain tumors and management of hydrocephalus. She has several publications in peer-reviewed journals and has presented at national meetings. She is a member of the Congress of Neurosurgeons and the Children’s Oncology Group.
Dr. Snyder has been with University at Buffalo Neurosurgery (UBNS) since 2011, after completing his fellowship training in endovascular neurosurgery with UBNS and spening six months as a research fellow at the Barrow Neurological Institute with Dr. Robert Spetzler. He completed his neurosurgical residency at University at Buffalo (UB) and received his PhD in biophysics under the guidance of Dr. Frederick Sachs, specializing in mechanoelectric transduction of cellular membranes. He is trained in all general neurosurgical procedures.
His extra training in open cerebrovascular techniques, as well as his endovascular fellowship, give him the necessary toolset for specialization in the comprehensive management of neurovascular pathology in both the brain and spinal cord, including treatment of aneurysms, arteriovenous malformations, arteriovenous fistulas, and stroke. He has special interests and expertise in physiological imaging of the brain and its use in the evaluation and management of acute stroke patients, as well as all endovascular techniques for acute stroke intervention for both extracranial and intracranial vascular occlusive disease.
Dr. Snyder has been awarded a Congress of Neurological Surgeons Vascular Fellowship for Cerebrovascular Research, a Toshiba Stroke Imaging Research Fellowship, the Gold Humanism in Excellence in Teaching, and was named UB Neurosurgery Resident of the Year.
His active research interests include use of CT Perfusion (CTP) for acute stroke management, application of perfusion imaging to on-table angiography, glasses-free 3D imaging in both the operating room and endovascular suite, as well as basic science research on the role of mechanosensitive ion channels both in aneurysm formation and vasospasm. He has published numerous articles and holds multiple patents. He is an active member of several national neurosurgical and interventional organizations and has given multiple CME lectures nationwide on the role of CTP in endovascular stroke management.
Dr. Zlotnick is an Interventional Cardiologist with the UBMD Division of Cardiovascular Medicine. He earned his medical degree from SUNY Upstate Medical University in Syracuse, N.Y., and completed his internal medicine residency, cardiovascular disease and interventional cardiology fellowships at Dartmouth-Hitchcock Medical Center in Lebanon, N.H. He also completed an additional year of training at The Ochsner Clinic Foundation in New Orleans, L.A., focusing on structural heart and peripheral vascular interventions. He is board-certified in internal medicine, cardiovascular disease, and interventional cardiology, with additional certifications in echocardiography, nuclear cardiology, and non-invasive vascular interpretation.
His interventional practice includes the evaluation and management of patients with complex coronary and structural heart disease. His practice also has a specialized focus on the evaluation and management of patients with peripheral vascular disease including endovascular therapies. Patient-care responsibilities are provided at the Gates Vascular Institute and at Buffalo General Medical Center on the consultative service and Cardiac Care Unit (CCU). Outpatient cardiac care services are also provided through the UBMD ambulatory practice at Dent Tower. Dr. Zlotnick is a member of the American College of Cardiology and American Registry for Diagnostic Medical Sonography.
Dr. Zlotnick received his B.S. in biology from the University of Rochester and his medical degree from SUNY Upstate Medical University. He completed his residency in internal medicine at Dartmouth-Hitchcock Medical Center and served as chief resident. Dr. Zlotnick completed his fellowships in cardiovascular disease and interventional cardiology at Dartmouth-Hitchcock, as well. He completed his fellowship in interventional cardiology and peripheral vascular intervention at the Ochsner Clinic Foundation.
He received the Excellence in Teaching Award of the Department of Medicine (2008) and the Dean’s Letter of Commendation for Outstanding Academic Performance during the third year of medical school.